(EMAILWIRE.COM, May 22, 2012 ) New York, NY -- Shares of NovaBay Pharmaceuticals (NBY) may have significant room to move higher, according to VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors.
With a science that could...
more
(EMAILWIRE.COM, May 22, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, reported today that Synergy Pharmaceuticals (SGYP) may be in a position to realize significant share price gains over the coming...
more
(EMAILWIRE.COM, May 21, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, believes that Ampio Pharmaceuticals (AMPE) may be poised for a rebound.
After a five percent drop on Friday, shares of Ampio...
more
(EMAILWIRE.COM, May 20, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, recaps last week's best stories and provides a look at multiple companies to watch during the coming trading week.
As expected,...
more
(EMAILWIRE.COM, May 01, 2012 ) Boca Raton, FL -- Dee Cohen, LCSW, has recently interviewed several best-selling authors who have battled addiction and who each have an inspiring story to tell about addiction and recovery. These stories have been included in a new book, Beyond Addiction that is now...
more
(EMAILWIRE.COM, May 01, 2012 ) New York, NY -- The recent pullback of Immunocellular Therapeutics (IMUC) shares may have opened up a buying opportunity, according to VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors.
Immunocellular...
more
(EMAILWIRE.COM, April 29, 2012 ) New York, NY -- At the conclusion of each week, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, examines some news items, stocks and stories that made headlines during the previous trading...
more
(EMAILWIRE.COM, April 28, 2012 ) New York, NY – Yasmin lawsuit settlements surrounding Bayer’s popular line of fourth-generation birth control pills have climbed to $142 million, according to reports. These U.S. lawsuits claim that the pharmaceutical company’s Yasmin line of oral contraceptives have...
more
(EMAILWIRE.COM, April 27, 2012 ) Tampa, Florida – The Pradaxa lawyers at Morgan and Morgan are investigating potential legal claims on behalf of Pradaxa users who suffered severe bleeding episodes while taking the blood thinning medication. These episodes, which include brain hemorrhages and gastrointestinal...
more
(EMAILWIRE.COM, April 25, 2012 ) Delray Beach, FL - Pharmacy-Schools.us is encouraging students interested in medicine to explore the opportunities available in the field of pharmacology. Pharmacology, the study of how drugs interact with living organisms, is growing much faster than other areas...
more
(EMAILWIRE.COM, April 25, 2012 ) New York City, NY -- Introduced onto the market in late 2011, Digesten-K was a revolutionary new product that offered relief from all digestive problems, not just components of them. It quickly gained a reputation for its remarkable results and attracted customers...
more
(EMAILWIRE.COM, April 25, 2012 ) Denmark -- For years, Danish head and neck cancer patients have had their chances of overcoming their cancer therapy improved by an add-on treatment to radiotherapy. Danish biotech company Azanta A/S has now received Orphan Drug Designation, which will facilitate...
more
(EMAILWIRE.COM, April 23, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, believes that an extended FDA approval decision time frame for a competitor will allow Synergy Pharmaceuticals (SGYP) to...
more
(EMAILWIRE.COM, April 23, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, believes that recent moves to sell off non-core assets by Pfizer may be an indication that company will look to replenish...
more
(EMAILWIRE.COM, April 16, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, believes that pending catalysts and distinct advantages over its competition could help Synergy Pharmaceuticals (SGYP) achieve...
more
